Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIFREE: Rifampin-free vs Rifampin-containing Regimen in Staphylococcal Prosthetic Valve Endocarditis
NCT07345325Phase 3Recruiting
- Sponsor
- CHU de Nantes
- Start
- Jun 2026
- Primary completion
- Dec 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rifampicin in Prosthetic valve endocarditis (PVE), sponsored by CHU de Nantes. Started Jun 2026; status: recruiting.
02
Drugs
rifampicin
03
Conditions
Prosthetic valve endocarditis (PVE)
Beyond the preview
Go deeper on NCT07345325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07345325.